Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
辉瑞、阿斯利康、赛诺菲和美因兹生物医学将提升欧洲的制药业水平
On Sunday, Pfizer (NYSE:PFE) and AstraZeneca Plc (NASDAQ:AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France, just ahead of this year's "Choose France" business summit. Together with the domestic Sanofi (NASDAQ:SNY), Pfizer, AstraZeneca will together invest €1.87 billion which is more than $2 billion to expand their operations in the country.
周日，辉瑞（纽约证券交易所代码：PFE）和阿斯利康集团（纳斯达克股票代码：AZN）等制药公司宣布，在今年的 “选择法国” 商业峰会之前，他们将在法国的业务中总共投资近10亿美元。阿斯利康将与国内赛诺菲（纳斯达克股票代码：SNY）、辉瑞、阿斯利康共同投资18.7亿欧元，超过20亿美元，用于扩大在该国的业务。
AstraZeneca committed 365 million euros, which is about $394 million, to enhance its facilities at its French manufacturing facility in Dunkirk. Pfizer pledged even more, making a commitment to invest 500 million euros or $540 million over the...
阿斯利康承诺提供3.65亿欧元（约合3.94亿美元），用于改善其位于...
登录免费看全文
登录/注册